Zelira Therapeutics Launches Tech to Create Pharma-grade Cannabis Tablets & Capsules

 Zelira Therapeutics Launches Tech to Create Pharma-grade Cannabis Tablets & Capsules

Zelira Therapeutics, a company that commercializes clinically validated cannabinoid medicines, launches ZYRAYDI™, its patented, licensable technology for the medical cannabis industry.

ZYRAYDI™ is a proprietary Enhanced Distillate Capture and Dissolution Matrix (EDCDM) technology designed to trap the distillate in a free-flow powder matrix and increase the rate of dissolution. The ZYRAYDI matrix contains pharmaceutical-grade excipients that are on the FDA-approved list of GRAS (Generally Recognized As Safe) ingredients, and can be adapted to fit requirements for vegan, gluten-free, allergen-free, non-GMO and other drug delivery forms.


Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers from Tablets & Capsules – all delivered right to your inbox! Sign up now!